Pulmonx Corporation
LUNG
$3.42
$0.164.91%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 19.84% | 22.01% | 22.34% | 26.26% | 27.14% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 19.84% | 22.01% | 22.34% | 26.26% | 27.14% |
| Cost of Revenue | 23.76% | 21.56% | 18.54% | 23.58% | 24.45% |
| Gross Profit | 18.48% | 22.16% | 23.72% | 27.22% | 28.10% |
| SG&A Expenses | 7.90% | 7.96% | 8.10% | 11.73% | 12.48% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.12% | 8.33% | 7.88% | 11.29% | 13.94% |
| Operating Income | 3.89% | 6.83% | 7.08% | 3.49% | -1.18% |
| Income Before Tax | 2.50% | 7.26% | 7.04% | 4.52% | 0.76% |
| Income Tax Expenses | -29.07% | -12.43% | 24.78% | 13.14% | 54.39% |
| Earnings from Continuing Operations | 2.79% | 7.31% | 6.75% | 4.37% | 0.38% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 2.79% | 7.31% | 6.75% | 4.37% | 0.38% |
| EBIT | 3.89% | 6.83% | 7.08% | 3.49% | -1.18% |
| EBITDA | 5.09% | 8.28% | 8.36% | 4.77% | -1.30% |
| EPS Basic | 5.78% | 10.02% | 9.36% | 6.90% | 2.78% |
| Normalized Basic EPS | 5.49% | 9.98% | 9.65% | 7.06% | 3.18% |
| EPS Diluted | 5.78% | 10.02% | 9.36% | 6.90% | 2.78% |
| Normalized Diluted EPS | 5.49% | 9.98% | 9.65% | 7.06% | 3.18% |
| Average Basic Shares Outstanding | 3.14% | 3.00% | 2.88% | 2.74% | 2.55% |
| Average Diluted Shares Outstanding | 3.14% | 3.00% | 2.88% | 2.74% | 2.55% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |